Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Paloma Marina de la Torre-Iglesias"'
Autor:
Zaid Dahma, Alexandra Ibáñez-Escribano, Cristina Fonseca-Berzal, Juan José García-Rodríguez, Covadonga Álvarez-Álvarez, Carlos Torrado-Salmerón, Santiago Torrado-Santiago, Paloma Marina de la Torre-Iglesias
Publikováno v:
Polymers, Vol 16, Iss 15, p 2174 (2024)
Indomethacin (IND) as a non-selective cyclooxygenase 1 and 2 inhibitor administered orally causes numerous adverse effects, mostly related to the gastrointestinal tract. Moreover, when applied exogenously in topical preparations, there are obstacles
Externí odkaz:
https://doaj.org/article/c1fe23f0819f4f3bb9143ec1caba7a76
Autor:
Zaid Dahma, Carlos Torrado-Salmerón, Covadonga Álvarez-Álvarez, Víctor Guarnizo-Herrero, Borja Martínez-Alonso, Guillermo Torrado, Santiago Torrado-Santiago, Paloma Marina de la Torre-Iglesias
Publikováno v:
Gels, Vol 10, Iss 3, p 207 (2024)
Meloxicam (MX) is a poorly water-soluble drug with severe gastrointestinal side effects. Topical hydrogel of hydroxypropyl guar (HPG) was formulated using a solid dispersion (SD) of MX with hydroxypropyl cellulose (LHPC) as an alternative to oral adm
Externí odkaz:
https://doaj.org/article/dfa8b2cdb3d74938847e77f04d9648cc
Autor:
Eva Navarro-Ruíz, Covadonga Álvarez-Álvarez, M Ángeles Peña, Carlos Torrado-Salmerón, Zaid Dahma, Paloma Marina de la Torre-Iglesias
Publikováno v:
Pharmaceutics, Vol 14, Iss 7, p 1504 (2022)
The aim of this research is the development of new colonic release systems of meloxicam (MLX) a non-steroidal anti-inflammatory drug (NSAIDs) with pH and time-dependent vehicles for cancer or autoimmune diseases. The colon has a higher pH than the re
Externí odkaz:
https://doaj.org/article/bbfb33b6ce1f43eab8c61549f0764acd
Autor:
Carlos Torrado-Salmerón, Víctor Guarnizo-Herrero, Guillermo Torrado, M. Ángeles Peña, Santiago Torrado-Santiago, Paloma Marina de la Torre-Iglesias
Publikováno v:
International Journal of Pharmaceutics. 631:122520
Atorvastatin is a potent lipid-lowering drug with poor solubility and high presystemic clearance that limits its therapeutic efficacy. The aim of this study was to develop solid dispersions and micellar systems to obtain fast-dissolving atorvastatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06e44e2f57fa4c9bc8611216d63de13f
https://doi.org/10.1016/j.ijpharm.2022.122520
https://doi.org/10.1016/j.ijpharm.2022.122520
Autor:
Paloma Marina de la Torre-Iglesias, Santiago Torrado-Santiago, Francisco Bolás-Fernández, Guillermo Torrado, Susana Torrado, Juan José García-Rodríguez
Publikováno v:
Drug Design, Development and Therapy
Paloma Marina de la Torre-Iglesias,1,2 Juan José García-Rodriguez,3 Guillermo Torrado,4 Susana Torrado,1,2 Santiago Torrado-Santiago,1,5 Francisco Bolás-Fernández3 1Department of Pharmaceutical Technology, Faculty of Pharmacy, Complutense Univers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4ea78c68d841d6df96ad5d1de683c1d
https://pubmed.ncbi.nlm.nih.gov/25258515
https://pubmed.ncbi.nlm.nih.gov/25258515
Autor:
Santiago Torrado-Santiago, Francisco Bolás-Fernández, M. Carmen Vegas-Sánchez, Juan José García-Rodríguez, Paloma Marina de la Torre-Iglesias, Susana Torrado-Durán
Publikováno v:
International journal of pharmaceutics. 403(1-2)
To improve the efficacy of mebendazole (MBZ), a poorly water-soluble drug, MBZ solid dispersions containing different proportions of low-substituted hydroxypropylcellulose (L-HPC) were prepared by lyophilization process. The physical characteristics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eeff910f71a786d702211de4ee23b6c
https://pubmed.ncbi.nlm.nih.gov/20934497
https://pubmed.ncbi.nlm.nih.gov/20934497